3 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow Vulvovaginitis: new trials by email Literature Review of Vulvovaginitis trials Research Report on Vulvovaginitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis SHR8008, Fluconazole - Recurrent Vulvovaginal Candidiasis | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 196 | 2021-09-14 | 2021-10-12 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis | Phase 2 / Phase 3 | Unknown | ProFem GmbH | 432 | 2019-10-01 | 2022-09-22 |
| Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Ketoconazole, Terconazole - Vaginal Candidiasis | Phase 3 | Unknown | Assiut University | 69 | 2018-04-01 | 2018-03-22 |
Bacterial Infections and Mycoses (3) · Candidiasis (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Infections (3) · Mycoses (3) · Urogenital Diseases (3) · Vaginal Diseases (3) · Vaginitis (3) · Vulvar Diseases (3) · Vulvitis (3)
Fluconazole (2) · Ketoconazole (1) · terconazole (1)
Assiut University (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · ProFem GmbH (1)
Austria (1) · China (1) · Poland (1) · Slovakia (1)